DFE Pharma has launched its Continuous Manufacturing (CM) platform, designed to support pharmaceutical companies in ...
“The global API manufacturing market is going through some major changes these days,” says Sean O’Brien, COO, Abzena. He ...
Dublin, April 10, 2018 (GLOBE NEWSWIRE) -- The "Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging" report has been added to ResearchAndMarkets.com's offering. The study ...
The "Contract Pharmaceutical Manufacturing, Research, and Packaging Market Forecasts to 2029" report has been added to ResearchAndMarkets.com's offering. This report aims to provide in-depth knowledge ...
South Korea-based LOTTE BIOLOGICS signed a contract manufacturing agreement for antibody therapeutics with Ottimo Pharma, a biopharmaceutical company developing PD1/VEGFR2 dual pathway antibodies ...
NEW YORK & MIAMI--(BUSINESS WIRE)--Aterian Investment Partners (“Aterian”), a private investment firm, is pleased to announce that one of its affiliates has entered into an agreement to recapitalize ...
Pharmaceutical Technology on MSN
Ampersand Capital acquires Purna Pharmaceuticals
Achelous Partners acted as investment banking and financial adviser to Purna during the transaction.
Contract development and manufacturing organizations (CDMOs) provide outsourcing options to biotechnology and pharmaceutical companies, helping them advance their drugs from the laboratory to the ...
Rising demand for advanced, cost-efficient medical technologies and the increasing shift by OEMs toward outsourcing is ...
With a pair of production facilities already on deck, a new contract development and manufacturing organization has surfaced in Europe. Based in Poland, biologics-focused Rezon Bio announced its ...
BETHLEHEM, Pa., January 15, 2026--(BUSINESS WIRE)--Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active pharmaceutical ingredients ...
Amid Eli Lilly's efforts to strengthen its global manufacturing network, the Indianapolis pharma giant is splashing more than $1 billion into its Indian operations, with plans to tap local partners ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results